AKTOCYTE: A Revolutionary Nutraceutical for Cancer Care
Recently, in a groundbreaking collaboration, scientists from the Department of Atomic Energy and M/s. IDRS Labs Pvt. Ltd., Bengaluru, have developed AKTOCYTE tablets, aiming to enhance the quality of life for cancer patients undergoing radiotherapy.
Key Points
- Remarkable Recovery in Pelvic Cancer Patients: AKTOCYTE tablets demonstrate exceptional efficacy in pelvic cancer patients undergoing radiotherapy, leading to significant recovery and eliminating the need for surgical interventions.
- Versatile Applications: Positioned as an adjuvant to cancer radiotherapy, a regenerative nutraceutical, an immunomodulator, and an antioxidant, AKTOCYTE showcases versatility in addressing various aspects of cancer care.
- Regulatory Approval: AKTOCYTE received approval from the Food Safety ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Successful Test of Naval Anti-Ship Missile (NASM-SR)
- 2 DRDO Successfully Tests VSHORADS
- 3 NASA’s Lunar Trailblazer Launched
- 4 ESA’s Euclid Telescope Discovers Rare Einstein Ring
- 5 ISRO Develops Indigenous 10-Ton Vertical Mixer
- 6 3D Structure of an Exoplanet’s Atmosphere Revealed
- 7 Novel Technique to Enhance Next-Gen Lighting
- 8 Revolutionary Drug Delivery System for Rheumatoid Arthritis
- 9 Successful Wet Tests of Matsya-6000
- 10 Project Waterworth
